RELATIVE POTENCY OF ANTI-DIABETIC COSTUS SPECIOSUSPLANT EXTRACT IN MOUSE FIBROBLAST CELL LINE
DOI:
https://doi.org/10.29121/granthaalayah.v4.i3.2016.2790Keywords:
Costus Speciosus, Mouse Fibroblast, Cell Differentiation, Relative Insulin PotencyAbstract [English]
Plant-derived compounds have been used clinically to treat type 2 diabetes for many years as they also exert additional beneficial effects on various other disorders. PI3K pathway is the major pathway activated by insulin receptor (IR). It induces glucose uptake, glycogen synthesis, protein synthesis, cell growth and differentiation. Hence metabolic assay was employed to assess glucose uptake based on the property of 3T3-L 1 cells to differentiate into adipocytes which can take up the glucose in medium due to the effect of insulin or insulin like molecules. The results of the current study showed that plants extract probably exerts its anti-diabetic properties by stimulating glucose uptake in adipocytes with significant inhibition of adipogenesis demonstrating reliable relative potency in comparision to the commercial insulin. The ability of existing therapies to target various aspects of the insulin resistance syndrome induces other metabolic abnormalities, chiefly those involved in lipid metabolism.
In this preliminary in-vitro study Costusspeciosus plant extract demonstrated to have significant relative potency in comparison to commercial Insulin which can be exploited to treat diabetes using natural herbal extracts
Current study leads researchers to elucidate the chemical structures, isolate active ingrediatents in the crude extract for such biological activities in reference to commercial and recombinant insulins.
Downloads
References
Bhat Vishnu, Asuti Naveen, KamatAkshay, SikarwarMukesh. S., Patil M. B. Antidiabetic activity of insulin plant (Costusigneus)leaf extract in diabetic rats Journal of Pharmacy Research 2010, 3(3),608-611
James DE & Piper RC, Insulin resistance, diabetes, and the insulin-regulated trafficking of GLUT-4. J Cell Biol 126 1994 1123-1126. DOI: https://doi.org/10.1083/jcb.126.5.1123
Baldea LAN, Martineau LC, Benhaddou-Andaloussi A, Arnason JT, Levy E, Haddad PS. Inhibition of intestinal glucose absorption by anti-diabetic medicinal plants derived from the James Bay Cree traditional pharmacopeia. J Ethnopharmacol. 2010;132(2):473–82. doi: 10.1016/j.jep.2010.07.055. [PubMed][Cross Ref] DOI: https://doi.org/10.1016/j.jep.2010.07.055
Klein G, Kim J, Himmeldirk K, Cao Y, Chen X. Antidiabetes and anti-obesity activity of Lagerstroemia speciosa. Evidence Based Complementary and Alternative Medicine. 2007; 4(4):401–8. doi: 10.1093/ecam/nem013. [PMC free article] [PubMed] [Cross Ref] DOI: https://doi.org/10.1093/ecam/nem013
Adams TE, Epa VC, Garrett TP & Ward CW 2000 Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57 1050-1093. DOI: https://doi.org/10.1007/PL00000744
Green H, Kehinde O. An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion. Cell. 1975;5(1):19–27. doi: 10.1016/0092-8674(75)90087-2. [PubMed][Cross Ref] DOI: https://doi.org/10.1016/0092-8674(75)90087-2
Tom Yates MJD, Schwarz PEH, Khunti K. Diabetes prevention: a call to action. Indian J Med Res.2011;134(November):579–82. doi: 10.4103/0971-5916.90979. [PMC free article] [PubMed] [Cross Ref] DOI: https://doi.org/10.4103/0971-5916.90979
Alonso-Castro AJ, Salazar-Olivo LA. The anti-diabetic properties of Guazumaulmifolia are mediated by the stimulation of glucose uptake in normal and diabetic adipocytes without inducing adipogenesis. J Ethnopharmacol. 2008;118(2):252–6. doi: 10.1016/j.jep.2008.04.007. [PubMed] [Cross Ref] DOI: https://doi.org/10.1016/j.jep.2008.04.007
Chan CH, Ngoh GC, Yusoff R. A brief review on anti diabetic plants: Global distribution, active ingredients, extraction techniques and acting mechanisms. Pharmacognosy Reviews. 2012;6(11):22. doi: 10.4103/0973-7847.95854. [PMC free article] [PubMed] [Cross Ref]. DOI: https://doi.org/10.4103/0973-7847.95854
Downloads
Published
How to Cite
Issue
Section
License
With the licence CC-BY, authors retain the copyright, allowing anyone to download, reuse, re-print, modify, distribute, and/or copy their contribution. The work must be properly attributed to its author.
It is not necessary to ask for further permission from the author or journal board.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
